跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ESSEPNA
Authorized
STANDARD
ESSEPNA
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
65f24efa9b3c8d80
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
65f24efa9b3c8d80
Drug Approval Canada Name
ESSEPNA
Product Name
ESSEPNA
Status
Marketed
Status Date
2023-01-25
Original Market Date
2023-01-25
Din
02510324
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:20.00
Atc Original
B05BA01 AMINO ACIDS
Atc Name
b 05 ba 01
Aig Number
1662682001
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
ALANINE
1.4 G / 100 ML
ARGININE
1.2 G / 100 ML
GLYCINE
1.1 G / 100 ML
HISTIDINE
0.3 G / 100 ML
LEUCINE
0.74 G / 100 ML
ISOLEUCINE
0.5 G / 100 ML
METHIONINE
0.43 G / 100 ML
PHENYLALANINE
0.51 G / 100 ML
PROLINE
1.12 G / 100 ML
SERINE
0.65 G / 100 ML
TRYPTOPHAN
0.2 G / 100 ML
TAURINE
0.1 G / 100 ML
THREONINE
0.44 G / 100 ML
TYROSINE
0.04 G / 100 ML
VALINE
0.62 G / 100 ML
LYSINE (L-LYSINE ACETATE)
0.66 G / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
65f24efa9b3c8d80
Type
Standard
Back to Health Canada Approvals
ESSEPNA - Health Canada Drug Approval Details